Carly Kenselaar

Stock Analyst at Citigroup

(2.98)

# 1,424

Out of 4,876 analysts

7

Total ratings

83.33%

Success rate

39.12%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$14.77	+116.66%	6	Jun 11, 2025
	KRYS Krystal Biotech	Initiates: Buy	$160	$138.88	+15.21%	1	Oct 12, 2023

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $14.77

Upside: +116.66%

Krystal Biotech

Oct 12, 2023

Initiates: Buy

Price Target: $160

Current: $138.88

Upside: +15.21%